SURF1 and chronic kidney disease: The SURF1-rs183853102A variant, associated with higher risk of ESKD in the UK-ROI collection, showed consistent effects in the Diabetic Cohort of the UKB (increased CKD risk and SCr levels, decreased eGFRCrea and eGFRCreaCysC), but not significant after multiple comparisons correction (Table 2).